Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

AbundRX vs Omnia TeleHealth

AbundRX
Graded #181

Higher grade

vs+10.399999999999991
Omnia TeleHealth
Graded #418

Lower grade

The verdict

AbundRX takes it — 66.6/100 to 56.2/100.

AbundRX grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. AbundRX (Abundant Wellness) is an online medical weight-care platform connecting patients with licensed clinicians for compounded GLP-1 treatment.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueAbundRX +22
67
45
Dose & formulationAbundRX +24
64
40
Clinical oversightOmnia TeleHealth +1
79
80
Labs & monitoringOmnia TeleHealth +8
53
61
FulfillmentAbundRX +12
74
62
Contract termsEven
55
55
AbundRX · left barOmnia TeleHealth · right bar

The numbers

MetricAbundRXOmnia TeleHealth
WeighScore66.6/10056.2/100
GradeCC
Scorecard rank#181#418
Semaglutide$179/mo (compounded)Not disclosed
Tirzepatide$279/mo (compounded)Not disclosed
CoverageCoverage not publishedCoverage not published
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
AbundRX

Graded #181 · C

Strengths

  • Two clear compounded GLP-1 pathways with transparent pricing — semaglutide $179/mo and tirzepatide $279/mo
  • Fast, free shipping and a simple few-minute online health assessment
  • Provider-guided care connecting patients with licensed US clinicians
  • Publishes Terms, Privacy, and Refund policies

Where it loses points

  • Claims LegitScript certification in text but displays no verifiable seal or listing
  • Compounded medications are not FDA-approved (the site discloses this) — not brand Wegovy, Ozempic, Zepbound, or Mounjaro
  • Compounding pharmacy not named; no HIPAA notice found; state availability not published
  • Heavily hedged marketing language ('may include', 'helping connect patients') — reads like a lead-generation platform
Omnia TeleHealth

Graded #418 · C

Strengths

  • LegitScript-certified; DNP-led by Blair Carmichael-Lober with 10+ years clinical experience
  • $69 flat consult fee — no insurance, no surprise bills; works with Belmar Pharma for compounded GLP-1
  • Both semaglutide and tirzepatide available; compounded options via Belmar at lower cost than brand
  • Weight loss visits include nutrition guidance, exercise recommendations, and behavioral coaching
  • Prescriptions sent to any pharmacy nationwide or coordinated through Belmar Pharma Solutions

Where it loses points

  • Only 17 states — specific states not publicly disclosed; must call (251) 220-8875 to confirm
  • Medication pricing is gated — not published on website; contact required for compounded GLP-1 cost
  • No labs mentioned or included — baseline bloodwork protocol not published on any page
  • Medication cost is a separate pharmacy bill; the $69 visit fee covers consult only
  • Smaller platform with limited public track record vs. larger national GLP-1 telehealth providers

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard